InvestorsHub Logo
Followers 155
Posts 2640
Boards Moderated 0
Alias Born 01/29/2004

Re: A deleted message

Monday, 01/17/2022 4:28:54 PM

Monday, January 17, 2022 4:28:54 PM

Post# of 461943
But it’s just ‘nonsense.’

I don’t think our deep knowledge posters have given this news [of profound Anavex 3-71 efficacy] the broad spectrum of interpretation which such clinical data deserves..

Well, actually several of us have.

But, as expected, with our pronouncements of the new drug’s profound efficacies against a diversity of diseases and conditions, along with a wonderful safety profile, we have been thoroughly castigated. “Nonsense” has been a recurring declaration. “Investors should pay no attention; dangerous mis-information.”

Of course, all of this is understandable. Indeed, what Anavex 3-71 therapeutically offers, safely, is hard to believe. More of the Anavex “too good to be true” stuff. Several prominent, respected posters have declared that until the drug is demonstrated to work in a real human disease, in humans, in a proper double-blind clinical trial, it must be considered “nonsense.”

Each reader will have to determine his or her own viewpoint. The remarkable preclinical science of Anavex 3-71 has been presented. For most, it will be discounted until the anticipated clinical trial(s) conclude. Understood.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News